Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1970-9366
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products ; volume:14 ; number:6 ; day:14 ; month:2 ; year:2019 ; pages:821-834 ; date:9.2019
Internal and emergency medicine ; 14, Heft 6 (14.2.2019), 821-834, 9.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11739-019-02045-z
- URN
-
urn:nbn:de:101:1-2020011606102245339037
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoeng, Julia
- Maeder, Serge
- Vanscheeuwijck, Patrick
- Peitsch, Manuel C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Do alternative tobacco products induce less adverse respiratory risk than cigarettes?
Risk assessment of biotechnology products
Intensive tobacco cultivations, a possible public health risk?
Tobacco smoking and the risk of gallbladder disease
Assessment of Nicotine delivery capabilities and evaluation of human health risk of metals associated with selected tobacco products
Parental risk perceptions of child exposure to tobacco smoke
Functional characterization of candidate risk CNVs in lung cancer
Functional characterization of candidate risk CNVs in lung cancer
Securitized products, financial regulation, and systemic risk
Risk management of startups of innovative products
Longevity risk measurement of life annuity products
Coronary age as a risk factor in the modified Framingham risk score
Do alternative tobacco products induce less adverse respiratory risk than cigarettes?
Risk assessment of biotechnology products
Intensive tobacco cultivations, a possible public health risk?
Tobacco smoking and the risk of gallbladder disease
Assessment of Nicotine delivery capabilities and evaluation of human health risk of metals associated with selected tobacco products
Parental risk perceptions of child exposure to tobacco smoke
Functional characterization of candidate risk CNVs in lung cancer
Functional characterization of candidate risk CNVs in lung cancer
Securitized products, financial regulation, and systemic risk
Risk management of startups of innovative products
Longevity risk measurement of life annuity products
Coronary age as a risk factor in the modified Framingham risk score
Do alternative tobacco products induce less adverse respiratory risk than cigarettes?
Risk assessment of biotechnology products
Intensive tobacco cultivations, a possible public health risk?
Tobacco smoking and the risk of gallbladder disease
Assessment of Nicotine delivery capabilities and evaluation of human health risk of metals associated with selected tobacco products
Parental risk perceptions of child exposure to tobacco smoke
Functional characterization of candidate risk CNVs in lung cancer
Functional characterization of candidate risk CNVs in lung cancer
Securitized products, financial regulation, and systemic risk
Risk management of startups of innovative products
Longevity risk measurement of life annuity products